Clinical trial
Doravirine, Rifapentine and Isoniazid Interaction
NCT03886701
Study timeline
Study start (actual)2019-04-22Date precision: day
Registry last updated2020-03-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Latent Tuberculosisunresolved
Human Immunodeficiency Virusunresolved
Drug Interaction Potentiationunresolved
Interventions
Sponsors & collaborators
Walter K. Kraftlead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03886701 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.